Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection

Journal of Infectious Diseases

Volumn 198, Issue 4, 2008, Pages 536-543

  Lilleri, Daniele ^a   Fornara, Chiara ^a   Revello, Maria Grazia ^a   Gerna, Giuseppe ^a,b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HUMAN; INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS TRANSMISSION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTORS, CCR7;

EID: 48749127711     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/590118     Document Type: Article

References (44)

1. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J 1965; 2:1099-102.
2. Klemola E, Kaariainen L, von Essen R, Haltia K, Koivuniemi A, von Bonsdorff CH. Further studies on cytomegalovirus mononucleosis in previously healthy individuals. Acta Med Scand 1967; 182:311-22.
3. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation following marrow transplantation. J Infect Dis 1986; 153:478-88.
4. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992; 166:1223-7.
5. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982; 306:945-9.
6. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-8.
7. Meyers JD, Flournoy N, Thomas E. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 1980; 142:816-24.
8. Reusser P, Riddell S, Meyers J, Greenberg P. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78:1373-80.
9. Hayes K, Alford CA, Britt WJ. Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis 1987; 156:615-21.
10. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 1991; 164:835-42.
11. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326:663-7.
12. Revello MG, Lilleri D, Zavattoni M, et al. Lymphoproliferative response in primary human cytomegalovirus infection (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 2006; 193:269-76.
13. Lilleri D, Fornara C, Furione M, Zavattoni M, Revello MG, Gerna G. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 2007; 195:1062-7.
14. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
15. + T cells comprise both naive and memory cells. J Immunol 1999; 162:7080-7.
16. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187:1395-402.
17. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-63.
18. Wherry EJ, Teichgräber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-34.
19. Lefrançois L, Marzo AL. The descent of memory T-cell subsets. Nat Rev Immunol 2006; 6:618-23.
20. + T cell response. J Immunol 2002; 168:5455-64.
21. Khan N, Best D, Bruton R, Nayak L, Rickinson AB, Moss PA. T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection. J Immunol 2007; 178:4455-65.
22. + T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 2005; 35:1795-804.
23. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18.
24. + T cells. J Gen Virol 2005; 86:275-84.
25. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998; 177:1170-5.
26. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
27. Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol 1998; 56:99-103.
28. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999; 14:57-66.
29. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004; 78:5535-45.
30. + T cells. J Immunol 2006; 177:4998-5005.
31. + T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 2006; 108:1406-12.
32. + T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest 2000; 106:1251-61.
33. Masopust D, Ha SJ, Vezys V, Ahmed R. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 2006; 177:831-9.
34. + T cells in healthy and immunosuppressed virus carriers. Blood 2001; 98:754-61.
35. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
36. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002; 111:837-51.
37. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
38. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101:4260-6.
39. + T cells. Blood 2007; 110:4360-6.
40. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101:2686-92.
41. EMRA cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J Virol 2007; 81:5759-65.
42. Carrasco J, Godelaine D, Van Pel A, Boon T, van der Bruggen P. CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 2006; 108:2897-905.
43. + T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 2002; 100:933-40.
44. Dunne PJ, Belaramani L, Fletcher JM, et al. Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+T cells during persistent infection. Blood 2005; 106:558-65.